Clinical trial

Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery…

NCT00162357 · Lantheus Medical Imaging, Industry · Completed

Key facts

NCT number NCT00162357
Title Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty
Official title Cardiolite-406; A Phase IV Open-Label, Randomized, Multi-Center Trial To Evaluate The Ability of Cardiolite Stress MPI to Detect Asymptomatic Restenosis in Diabetic Patients Who Have Undergone Percutaneous Coronary Intervention
Lead sponsor Lantheus Medical Imaging, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Diabetes Mellitus, Type 2, Coronary Restenosis
Intervention type Drug
Interventions Technetium Tc99m Sestamibi
Enrollment 106
Start date Apr 1, 2004
Primary completion Dec 1, 2005
Completion Dec 1, 2005
First posted Sep 13, 2005
Last update posted Apr 15, 2011
Countries Puerto Rico, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies